13F

Stock

Alzamend Neuro, Inc.

ALZN · held by 12 managers

Reported value

$122.4K

Holders

12

+2 new · −4 exited

Holders’ est. mark

−$47.5K

Price effect on 8 books still in the name

Largest holder

$48.4K

GEODE CAPITAL MANAGEMENT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC45.7K$48.4K−$20.9KCut−$1.64K
VANGUARD FIDUCIARY TRUST CO21K$22.3KHeld
MORGAN STANLEY18K$19.1K−$13.7KCut−$13.7K
Clearstead Advisors, LLC10K$10.6K−$7.6KCut−$7.6K
Tower Research Capital LLC (TRC)6.18K$6.55K−$1.58KAdded$2.77K
CITIGROUP INC5.23K$5.54KNew
UBS Group AG4.5K$4.77K−$3.42KCut−$39.9K
VANGUARD CAPITAL MANAGEMENT LLC4.4K$4.66KHeld
BlackRock, Inc.437$463−$332Cut−$332
SBI Securities Co., Ltd.22$23−$17Cut−$17
Caitong International Asset Management Co., Ltd4$4New
HARBOR INVESTMENT ADVISORY, LLC1$1−$1Cut−$1

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.